Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 240

1.

Are there fakes and frauds in your nebulizer?

Allergy & Asthma Network Mothers of Asthmatics.

School Nurse News. 2005 Mar;22(2):15-7.

PMID:
15875950
2.

FDA inspections find unsafe practices in compounding pharmacies.

McCarthy M.

BMJ. 2013 Apr 16;346:f2414. doi: 10.1136/bmj.f2414. No abstract available.

PMID:
23592476
3.

Protecting consumers from counterfeit drugs.

[No authors listed]

FDA Consum. 2004 May-Jun;38(3):12-3. No abstract available.

4.

Are metered-dose inhalers with holding chambers better than nebulizers for treating acute asthma?

Epling J, Chang MH.

Am Fam Physician. 2003 Jan 1;67(1):62-4. No abstract available.

5.

Building a case for evidence-based practice: inhalers vs. nebulizers.

Melnyk BM.

Pediatr Nurs. 1999 Jan-Feb;25(1):102-3, 101. No abstract available.

PMID:
10335257
6.

[Drug counterfeiting and counter measures. Study by the Hungarian National Alliance Against Drug Counterfeiting].

[No authors listed]

Psychiatr Hung. 2009;24(3):205-14. Hungarian. No abstract available.

PMID:
20017282
7.

Inhalation devices in adult asthma.

Csontos Z.

Acta Microbiol Immunol Hung. 1998;45(1):123-9. Review. No abstract available.

PMID:
9595162
8.

Better delivery ensures low asthma drug doses.

[No authors listed]

Community Nurse. 2001 Jan;6(12):6. No abstract available.

PMID:
11982064
9.

Inhalation-device polypharmacy in asthma.

McDonald VM, Gibson PG.

Med J Aust. 2005 Mar 7;182(5):250-1. No abstract available.

PMID:
15748140
10.

Monitoring flow rates and retention of inhalation techniques using the in-check dial device in adult asthmatics.

Fiato KL, Iwamoto GK, Harkins MS, Morelos J.

J Asthma. 2007 Apr;44(3):209-12.

PMID:
17454340
11.

[Inhalation therapy in children younger than 2 years].

Roorda RJ, Brand PL.

Ned Tijdschr Geneeskd. 1998 Oct 3;142(40):2212-3; author reply 2214-5. Dutch. No abstract available.

PMID:
9864484
12.

Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.

Kastango ES.

JPEN J Parenter Enteral Nutr. 2012 Mar;36(2 Suppl):38S-39S. doi: 10.1177/0148607111434779. Epub 2012 Jan 24.

PMID:
22275322
13.

[The effect of particle size and amount of inhalation on the pulumonary function testsn in asthmatic children].

Yamaguchi H, Oosika E, Nakano H, Kaneko I, Nakayama T, Mitubayashi K, Siigai N, Okada F, Mitubayashi T, Sasaki N, Suzuki I, Akasaka T.

Arerugi. 2004 Nov;53(11):1152-62. Japanese.

PMID:
15719653
15.

[On what criteria is the choice of an inhaler made for the treatment of asthma?].

Virchow JC.

Rev Pneumol Clin. 2005 Sep;61(Spec no. 2):3S15-9. French. No abstract available.

PMID:
16272996
16.

Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists.

[No authors listed]

Am J Hosp Pharm. 1993 Jul;50(7):1452-61. No abstract available.

PMID:
8362883
17.

Measuring the assessment and counseling provided with the supply of nonprescription asthma reliever medication: a simulated patient study.

Schneider CR, Everett AW, Geelhoed E, Kendall PA, Clifford RM.

Ann Pharmacother. 2009 Sep;43(9):1512-8. doi: 10.1345/aph.1M086. Epub 2009 Aug 18.

PMID:
19690228
18.

Asthma medication delivery devices.

Meadows-Oliver M, Banasiak NC.

J Pediatr Health Care. 2005 Mar-Apr;19(2):121-3. Review. No abstract available.

PMID:
15750559
19.

Pharmaceutical and Medical Devices: FDA Oversight.

White RS; Thomson Reuters Accelus.

Issue Brief Health Policy Track Serv. 2015 Dec 28:1-97. No abstract available.

PMID:
27116797
20.

Supplemental Content

Support Center